ClinConnect ClinConnect Logo
Search / Trial NCT05534009

Health Care Workers Cohort Study in the EuCARE Project (EuCARE-HCW)

Launched by EURESIST NETWORK GEIE · Sep 6, 2022

Trial Information

Current as of June 29, 2025

Recruiting

Keywords

ClinConnect Summary

The EuCARE-HCW study is looking at how COVID-19 affects healthcare workers, specifically focusing on their vaccination and infection history. This research involves gathering information and samples from healthcare workers across eight countries, including Portugal, Italy, and Mexico. The goal is to understand how different variants of the virus might impact the body’s immune response, including how well vaccines work against these variants.

If you're a healthcare worker aged 18 or older and have information about your COVID-19 vaccination and infection history, you may be eligible to participate in this study. There are no specific exclusions, so most healthcare workers can join. Participants will provide samples and information that will help researchers analyze how the virus and vaccines interact. Your involvement could contribute valuable insights into improving COVID-19 responses in the healthcare community.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • The study subjects will be selected based on the following inclusion criteria:
  • 1. Adult (\>18 years) HCW with mandatory information on their SARS-CoV-2 infection and vaccination status.
  • 2. For those with a history of SARS-CoV-2 infection, diagnosis obtained by detection of SARS-CoV-2 RNA
  • 3. Having a signed informed consent when required by ethical approval
  • Exclusion Criteria: NONE

About Euresist Network Geie

Euresist Network GEIE is a collaborative research initiative focused on advancing the understanding and management of antibiotic resistance in healthcare settings. Comprising a consortium of academic institutions, healthcare providers, and industry partners, Euresist aims to facilitate innovative clinical trials and studies that explore the efficacy of novel therapeutic approaches and preventive strategies against resistant infections. By leveraging a multidisciplinary approach, the network strives to enhance patient outcomes, inform public health policies, and contribute to the global effort in combating antimicrobial resistance.

Locations

Düsseldorf, , Germany

Hanoi, , Vietnam

Lisbon, , Portugal

Milan, , Italy

Milan, , Italy

Vilnius, , Lithuania

Villahermosa, , Mexico

Patients applied

0 patients applied

Trial Officials

CRISTINA TOSCANO, DR

Study Chair

Centro Hospitalar de Lisboa Ocidental (CHLO)

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials